Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) FCF Margin (2016 - 2025)

CorMedix's FCF Margin history spans 12 years, with the latest figure at 72.11% for Q4 2025.

  • For Q4 2025, FCF Margin rose 9013.0% year-over-year to 72.11%; the TTM value through Dec 2025 reached 55.43%, up 17438.0%, while the annual FY2025 figure was 55.43%, 17213.0% up from the prior year.
  • FCF Margin for Q4 2025 was 72.11% at CorMedix, up from 29.11% in the prior quarter.
  • Across five years, FCF Margin topped out at 214684.33% in Q2 2024 and bottomed at 89069.3% in Q3 2022.
  • The 5-year median for FCF Margin is 119.23% (2024), against an average of 12484.47%.
  • The largest annual shift saw FCF Margin skyrocketed 20698320bps in 2023 before it tumbled -21460892bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 11522.31% in 2021, then crashed by -84bps to 21155.46% in 2022, then surged by 661bps to 118603.6% in 2023, then tumbled by -100bps to 18.02% in 2024, then skyrocketed by 500bps to 72.11% in 2025.
  • Per Business Quant, the three most recent readings for CRMD's FCF Margin are 72.11% (Q4 2025), 29.11% (Q3 2025), and 75.42% (Q2 2025).